marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-11-2023
Satsuma Pharmaceuticals Financial Ratios 2011-2024 | STSA
Annual Financial Ratios Satsuma Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -2.4 | -2.1 | -5.3 | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.2 | -1.8 | -2.7 | -4.8 | -7.2 | -9.3 | - | - | - | - | - | - |
EV (Enterprise Value) |
18.9 M | 114 M | 74.1 M | 138 M | 13.3 M | 7.42 M | - | - | - | - | - | - |
EBITDA per Share |
-2.2 | -1.74 | -2.7 | -4.9 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-2.2 | -1.4 | -4.6 | - | - | - | - | - | - | - | - | |
PEG |
- | 0.03 | 0.03 | - | - | - | - | - | - | - | - | |
P/B |
0.6 | 1.2 | 1.4 | 1.3 | - | - | - | - | - | - | - | - |
P/CF |
-0.5 | -2.8 | -2.1 | -5.0 | - | - | - | - | - | - | - | - |
ROE % |
-149.61 | -50.50 | -66.12 | -24.43 | - | - | - | - | - | - | - | - |
ROA % |
-127.51 | -46.59 | -58.70 | -22.31 | - | - | - | - | - | - | - | - |
ROCE % |
-151.52 | -50.49 | -66.21 | -24.41 | - | - | - | - | - | - | - | - |
Current Ratio |
6.8 | 12.9 | 9.2 | 14.4 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Satsuma Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.31 | - | -0.48 | -0.52 | -0.49 | - | -0.42 | -0.38 | -0.48 | -0.72 | -0.69 | -0.65 | -0.68 | -0.62 | -2.26 | -5.48 | -2.51 | -2.17 | -1.48 | -2.07 | -1.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.48 | -0.52 | -0.49 | - | -0.42 | -0.37 | -0.47 | -0.72 | -0.69 | -0.66 | -0.7 | -0.65 | -2.29 | -5.53 | -2.39 | -2.11 | -1.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-94.16 | -62.52 | -74.04 | -63.43 | -50.15 | -28.36 | -45.70 | -50.92 | -57.32 | -66.12 | -58.14 | -48.56 | -38.35 | -24.43 | 4.26 | 24.51 | 56.61 | 59.05 | 39.73 | 26.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-84.33 | -57.04 | -67.94 | -58.66 | -47.11 | -26.90 | -42.30 | -46.26 | -51.43 | -58.70 | -51.86 | -43.54 | -34.61 | -22.31 | -50.49 | -68.82 | -63.83 | -61.60 | -24.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-96.39 | -63.13 | -74.65 | -63.64 | -50.18 | -28.35 | -45.70 | -51.10 | -57.83 | -67.18 | -59.60 | -50.03 | -39.61 | -25.04 | 3.56 | 24.09 | 56.54 | 58.89 | 40.06 | 26.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.5 | 6.8 | 11.3 | 10.1 | 14.0 | 12.9 | 18.5 | 17.9 | 24.4 | 8.9 | 8.9 | 8.9 | 8.9 | 11.5 | 11.5 | 11.5 | 11.5 | 0.9 | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency